Increased Serum Adipokines Implicate Chronic Inflammation in the Pathogenesis of Overactive Bladder Syndrome Refractory to Antimuscarinic Therapy
Open Access
- 1 October 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (10), e76706
- https://doi.org/10.1371/journal.pone.0076706
Abstract
Recent studies have shown that chronic inflammation is involved in overactive bladder (OAB) syndrome. OAB could be a subtype of neurogenic inflammation. This pilot study investigated serum adipokine levels in patients with OAB refractory to antimuscarinic therapy. Thirty consecutive patients with OAB-dry (n = 16) or OAB-wet (n = 14) refractory to previous antimuscarinic treatment were prospectively enrolled in this study, a group of 26 normal subjects without lower urinary tract symptoms served as controls. Concentrations of serum C-reactive protein (CRP), nerve growth factor (NGF), and adipokines including interleukins ([IL], IL-1β, IL-6, IL-8), tumor necrosis factor (TNF)-α, monocyte chemotactic protein (MCP)-1, insulin, and leptin were quantified using a bead-based human serum adipokine panel B kit. Data were analyzed using the LX 200 platform. Patients were further classified as having dry or wet OAB and having medical diseases or not. The serum CRP, NGF, and adipokine levels were compared between OAB patients and the controls, and between OAB subgroups. The serum concentrations of CRP, NGF, IL-1β, IL-6, IL-8, and TNF-α in OAB-dry and OAB-wet patients were significantly higher than among the controls. There was no significant difference in adipokine levels between OAB-dry and OAB-wet, or between OAB patients with and without medical diseases. Serum CRP and NGF levels were significantly higher only in OAB-wet or OAB patients with medical diseases than among controls. The MCP-1 levels, on the other hand, were significantly higher in OAB-dry or OAB patients with disease, than the controls. Both OAB-dry and OAB-wet patients showed increased serum CRP, NGF, and adipokine levels compared with the controls, suggesting chronic inflammation of the bladder involving both peripheral and central mechanisms in all OAB patients refractory to antimuscarinic therapy. The increased serum adipokine levels were not relevant to medical diseases.Keywords
This publication has 42 references indexed in Scilit:
- Urinary Chemokines as Noninvasive Predictors of Ulcerative Interstitial CystitisJournal of Urology, 2012
- Cytokine Effects on Gap Junction Communication and Connexin Expression in Human Bladder Smooth Muscle Cells and Suburothelial MyofibroblastsPLOS ONE, 2011
- Elevation of serum c‐reactive protein in patients with OAB and IC/BPS implies chronic inflammation in the urinary bladderNeurourology and Urodynamics, 2011
- Evidence for Overlap Between Urological and Nonurological Unexplained Clinical ConditionsJournal of Urology, 2009
- DECREASED SENSORY RECEPTORS P2X 3 AND TRPV1 IN SUBUROTHELIAL NERVE FIBERS FOLLOWING INTRADETRUSOR INJECTIONS OF BOTULINUM TOXIN FOR HUMAN DETRUSOR OVERACTIVITYJournal of Urology, 2005
- Monocyte Chemoattractant Protein-1 Production by Human Detrusor Smooth Muscle CellsJournal of Urology, 2004
- Arrest ChemokinesMicrocirculation, 2003
- HISTOLOGICAL AND NEUROTROPHIC CHANGES TRIGGERED BY VARYING MODELS OF BLADDER INFLAMMATIONJournal of Urology, 2001
- Multiple Urinary Cytokine Levels of Bacterial CystitisJournal of Urology, 1997
- Neural input regulates tissue NGF and growth of the adult rat urinary bladderJournal of the Autonomic Nervous System, 1994